Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug (IMAGE)

DOE/Oak Ridge National Laboratory

Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug

Caption

Neutron scattering experiments show that when telaprevir binds to the protease, the amino acid sites will change their electric charges by altering their protonation states.

Credit

Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.